Way Huang

Overview

President of Henlius Biopharmaceutical who led the company from biosimilar pioneer to global biologics innovator with products approved in 70+ countries. Henlius under Way Huang was the first company to receive EMA approval for a biosimilar manufactured in China, establishing a new global manufacturing precedent. Way Huang describes Henlius as a 16-year-old Hong Kong-listed company with 10 products on the market, seven of which are sold outside China. (Segment 3 (10:00-15:00))